register

News & Trends - MedTech & Diagnostics

Device Technologies expands APAC footprint

Health Industry Hub | July 29, 2024 |

MedTech & Diagnostics News: Device Technologies Group has made its first acquisition in Southeast Asia with a focus on Malaysia and Singapore.

The company has entered into an agreement to acquire the Venusys and Infinity Group of Companies, which includes Fusion Scientific, Bits Medical, and Vennbio Nutriceutical.

This move marks Device Technologies Group’s entry into the point-of-care imaging technology market and enhances its presence in the aesthetics sector. The acquisition aims to leverage Device’s Asia Pacific footprint to expand beyond Malaysia and Singapore.

Nathaniel McLay, Managing Director Asia at Device Technologies Group, expressed enthusiasm about the acquisition, stating, “This is a significant advancement for Device Technologies Group. This purchase will enable us to advance our mission of delivering cutting-edge solutions and exceptional service to healthcare professionals across the APAC region.”

Founded in 2005, Venusys Medical Sdn Bhd specialises in laser- and light-based equipment, serving the aesthetic and surgical markets in Malaysia. Infinity Medical Sdn Bhd, established in 2003, is a key player in Malaysia’s healthcare sector, focusing on distributing point-of-care imaging equipment.

The acquisition also includes Bits Medical, providing radiographic equipment and support services; Fusion Scientific, involved in medical-grade skincare solutions; and Vennbio Nutriceutical, known for skin whitening products.

McLay emphasised, “It was clear that both Venusys, Infinity Medical and their affiliated companies align perfectly with our strategic growth plan and share our values of delivering superior health outcomes for our customers and patients. We’re incredibly excited about the opportunities this partnership will bring to the region,”

In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


Human Resources

AI in recruitment: Women see bias reduction, men fear losing their competitive edge

AI in recruitment: Women see bias reduction, men fear losing their competitive edge

Health Industry Hub | October 14, 2024 |

People & Culture: New Australian research has found that throughout the job recruitment process women believe artificial intelligence assessments reduce […]

More


News & Trends - MedTech & Diagnostics

Roche Diagnostics' genomic testing paves the way for personalised cancer care

Roche Diagnostics’ genomic testing paves the way for personalised cancer care

Health Industry Hub | October 14, 2024 |

Diagnostics & MedTech News: Increased adoption of personalised medicine has brought comprehensive genomic profiling (CGP) to the forefront. Monash Health […]

More


News & Trends - MedTech & Diagnostics

Aussie medtech on the brink of another acquisition

Aussie medtech on the brink of another acquisition

Health Industry Hub | October 14, 2024 |

MedTech & Diagnostics News: An Australian private equity firm is gearing up for a significant exit, reportedly valuing the medical […]

More


News & Trends - Pharmaceuticals

A clear appetite for constructive change: Senator Hughes on Metastatic Breast Cancer Awareness Day

A clear appetite for constructive change: Senator Hughes on Metastatic Breast Cancer Awareness Day

Health Industry Hub | October 14, 2024 |

Pharma News: The survival rates for women and men diagnosed with breast cancer have improved significantly, but for more than […]

More


This content is copyright protected. Please subscribe to gain access.